Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications

Journal article

Munis AM. et al, (2021), Molecular Therapy - Methods and Clinical Development, 20, 237 - 246

DEVELOPMENT OF PROTOCOLS FOR MOUSE GLP-TOXICOLOGY STUDIES

Conference paper

Sinadinos A. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S196 - S196

SINGLE-CELL ASSAYS FOR QUANTIFYING MRNA AND PROTEIN DURING CYSTIC FIBROSIS GENE THERAPY TRIALS

Conference paper

Sinadinos A. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S203 - S203

TOWARDS A FIRST-IN-HUMAN TRIAL WITH A PSEUDOTYPED LENTIVIRUS

Conference paper

Alton EW. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S224 - S224

Gene therapy for respiratory diseases; progress and a changing context.

Journal article

Alton EW. et al, (2020), Hum Gene Ther

Improving the Quantification of rSIV.F/HN Vectors for Cystic Fibrosis Gene Therapy Using Droplet Digital PCR

Conference paper

Gamlen T. et al, (2020), MOLECULAR THERAPY, 28, 223 - 223

Large-Scale, High-Throughput Production of rSIV.F/HN Vectors

Conference paper

Viegas MFA. et al, (2020), MOLECULAR THERAPY, 28, 201 - 201

Lentiviral-Mediated Expression of Monoclonal Antibodies in the Lung to Protect Against Influenza

Conference paper

Du Y. et al, (2020), MOLECULAR THERAPY, 28, 60 - 60

Rapid Determination of rSIV.F/HN Lentiviral Vector Titre

Conference paper

Conway CC. et al, (2020), MOLECULAR THERAPY, 28, 534 - 534

Emerging gene therapies for cystic fibrosis.

Journal article

Miah KM. et al, (2019), Expert Rev Respir Med, 13, 709 - 725

Gene therapy for surfactant protein B deficiency using recombinant AAV

Conference paper

Meyer-Berg H. et al, (2019)

Load More